Follow
IWALOYE Opeyemi
IWALOYE Opeyemi
Federal University of Technology Akure
Verified email at aaua.edu.ng
Title
Cited by
Cited by
Year
Saponins in cancer treatment: Current progress and future prospects
OO Elekofehinti, O Iwaloye, F Olawale, EO Ariyo
Pathophysiology 28 (2), 250-272, 2021
732021
Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2
OO Elekofehinti, O Iwaloye, SS Josiah, AO Lawal, MO Akinjiyan, EO Ariyo
Molecular Diversity 25, 1761-1773, 2021
502021
In silico molecular studies of natural compounds as possible anti-Alzheimer’s agents: ligand-based design
O Iwaloye, OO Elekofehinti, AI Momoh, K Babatomiwa, EO Ariyo
Network Modeling Analysis in Health Informatics and Bioinformatics 9, 1-14, 2020
432020
Insight into glycogen synthase kinase-3β inhibitory activity of phyto-constituents from Melissa officinalis: in silico studies
O Iwaloye, OO Elekofehinti, EA Oluwarotimi, B Kikiowo, TM Fadipe
In silico pharmacology 8, 1-13, 2020
412020
Therapeutic potential of Chromolaena odorata phyto-constituents against human pancreatic α-amylase
B Kikiowo, JA Ogunleye, O Iwaloye, TT Ijatuyi
Journal of Biomolecular Structure and Dynamics 40 (4), 1801-1812, 2022
402022
A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 …
TO Johnson, AE Adegboyega, OA Ojo, AJ Yusuf, O Iwaloye, ...
Frontiers in medicine 9, 907583, 2022
352022
Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2
TO Johnson, AE Adegboyega, O Iwaloye, OA Eseola, W Plass, B Afolabi, ...
Journal of Pharmacological Sciences 147 (1), 62-71, 2021
352021
Discovery of potential visfatin activators using in silico docking and ADME predictions as therapy for type 2 diabetes
OO Elekofehinti, OC Ejelonu, JP Kamdem, OB Akinlosotu, A Famuti, ...
Beni-Suef University Journal of Basic and Applied Sciences 7 (2), 241-249, 2018
342018
Biological activities of Chromolaena odorata: A mechanistic review
F Olawale, K Olofinsan, O Iwaloye
South African Journal of Botany 144, 44-57, 2022
312022
Molecular dynamics simulation and pharmacokinetics studies of ombuin and quercetin against human pancreatic α-amylase
B Kikiowo, I Ahmad, AA Alade, T T. Ijatuyi, O Iwaloye, HM Patel
Journal of Biomolecular Structure and Dynamics 41 (20), 10388-10395, 2023
282023
Discovery of traditional Chinese medicine derived compounds as wild type and mutant Plasmodium falciparum dihydrofolate reductase inhibitors: induced fit docking and ADME studies
O Iwaloye, OO Elekofehinti, B Kikiowo, TM Fadipe, MO Akinjiyan, ...
Current drug discovery technologies 18 (4), 554-569, 2021
282021
Momordica charantia silver nanoparticles modulate SOCS/JAK/STAT and P13K/Akt/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats
OO Elekofehinti, VO Oyedokun, O Iwaloye, AO Lawal, OC Ejelonu
Journal of Diabetes & Metabolic Disorders 20, 245-260, 2021
272021
Identification of main protease of coronavirus SARS-CoV-2 (Mpro) Inhibitors from Melissa officinalis
OO Elekofehinti, O Iwaloye, CD Famusiwa, O Akinseye, JBT Rocha
Current drug discovery technologies 18 (5), 38-52, 2021
232021
Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease
BE Oyinloye, O Iwaloye, BO Ajiboye
Scientific African 12, e00826, 2021
232021
Phytochemicals from Nigerian medicinal plants modulate therapeutically-relevant diabetes targets: insight from computational direction
F Olawale, K Olofinsan, O Iwaloye, TE Ologuntere
Advances in Traditional Medicine, 1-15, 2021
212021
Virtual screening of natural compounds as selective inhibitors of polo-like kinase-1 at C-terminal polo box and N-terminal catalytic domain
F Olawale, O Iwaloye, OO Elekofehinti
Journal of Biomolecular Structure and Dynamics 40 (24), 13606-13624, 2022
202022
Identification of lead compounds from large natural product library targeting 3C-like protease of SARS-CoV-2 using E-pharmacophore modelling, QSAR and molecular dynamics simulation
OO Elekofehinti, O Iwaloye, OR Molehin, CD Famusiwa
In Silico Pharmacology 9 (1), 49, 2021
162021
Predictive hybrid paradigm for cytotoxic activity of 1, 3, 4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural …
PO Chukwuemeka, HI Umar, O Iwaloye, OM Oretade, CB Olowosoke, ...
Journal of Biomolecular Structure and Dynamics 40 (18), 8518-8537, 2022
142022
Newly designed compounds from scaffolds of known actives as inhibitors of survivin: Computational analysis from the perspective of fragment-based drug design
OO Elekofehinti, O Iwaloye, F Olawale, PO Chukwuemeka, IM Folorunso
In Silico Pharmacology 9, 1-16, 2021
142021
Homology modelling, vHTS, pharmacophore, molecular docking and molecular dynamics studies for the identification of natural compound-derived inhibitor of MRP3 in acute …
F Olawale, O Iwaloye, K Olofinsan, OM Ogunyemi, GA Gyebi, IM Ibrahim
Chemical Papers 76 (6), 3729-3757, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20